Constructed growth charts and nutrition for pontocerebellar hypoplasia type 2A
Developmental Medicine & Child Neurology · 2026
DOI: 10.1111/dmcn.16394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2026. Verfasst von Alice Kuhn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropediatrics and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Growth Charts, Body Height, Olivopontocerebellar Atrophies, Body Weight. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chan Zuckerberg Initiative.
Abstract (Originalsprache)
Aim
To calculate growth charts for pontocerebellar hypoplasia (PCH) type 2A (PCH2A) and compare them to German reference charts, especially with regard to nutritional aspects.
Method
Data were gathered from a cohort of patients with genetically confirmed PCH2A, who were predominantly recruited through the German PCH patient network (65 patients [33 female, 32 male] at a mean age of 8 years 7 months). We collected data retrospectively using a parent questionnaire, and from medical records (December 2020–September 2022). Disease‐specific growth charts were prepared from predominantly longitudinal data using the gamlss package implemented in R. Sex‐disaggregated growth charts for PCH2A were compared to German reference data from the Kinder‐ und Jugendgesundheitssurvey (German Health Interview and Examination Survey for Children and Adolescents).
Results
The height and weight of participants with PCH2A were within the reference range at birth. Mean height was significantly lower at 6 months of age, weight at 3 months, and body mass index at 4 months. These deviations were also mostly significant later on. Head circumference in individuals with PCH2A was significantly below average at birth; all participants showed severe and progressive microcephaly in the further course. Caloric intake was within or above reference values.
Interpretation
Participants with PCH2A exhibited progressive microcephaly and frequently failed to thrive. Disease‐specific growth charts are a helpful tool to monitor those with PCH2A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neuropediatrics and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
- German PCH Patient Network (PCH-Familie e.V.), Böblingen, Germany.
- Hertie Institute for Clinical Brain Research, Medical Faculty, University of Tübingen, Tübingen, Germany.
- Zoological Institute, Karlsruhe Institute of Technology, Karlsruhe, Germany.
- Institute of Biological and Chemical Systems-Functional Molecular Systems Karlsruhe Institute of Technology, Karlsruhe, Germany.
ORCID-Profile: Alice Kuhn, Maren Hackenberg, Simone Mayer, Ingeborg Krägeloh-Mann, Samuel Groeschel, Wibke G Janzarik
Förderung
- Chan Zuckerberg Initiative
Zitieren
APA
Kuhn, A., Hackenberg, M., Klauser, A. L., Herrmann, A., Matilainen, J., Mayer, S., Frölich, S., Krägeloh-Mann, I., Groeschel, S., & Janzarik, W. G. (2026). Constructed growth charts and nutrition for pontocerebellar hypoplasia type 2A. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.16394
Vancouver
Kuhn A, Hackenberg M, Klauser AL, Herrmann A, Matilainen J, Mayer S, et al. Constructed growth charts and nutrition for pontocerebellar hypoplasia type 2A. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.16394
BibTeX
@article{Kuhn2026,
author = {Kuhn, Alice and Hackenberg, Maren and Klauser, Anna-Lena and Herrmann, Antonia and Matilainen, Julia and Mayer, Simone and Frölich, Saskia and Krägeloh-Mann, Ingeborg and Groeschel, Samuel and Janzarik, Wibke G},
title = {Constructed growth charts and nutrition for pontocerebellar hypoplasia type 2A},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.16394}
}
EUVIMED